The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of disposal of Euston House

14 Mar 2019 07:00

RNS Number : 7947S
Stenprop Limited
14 March 2019
 

 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

 

COMPLETION OF DISPOSAL OF EUSTON HOUSE IN LONDON FOR £95 MILLION

14 March 2019

Further to the announcement made by the Company on 10 January 2019, Stenprop announces that the sale of its Euston House office building in central London has now completed.

Stenprop has taken the strategic decision that its objective to deliver sustainable, growing income to shareholders is best achieved by becoming a specialised UK multi-let industrial (MLI) property company. This strategic repositioning means that Stenprop intends, over the next few years, to sell all its non-MLI assets and utilise the sale proceeds to build a focused UK MLI business.

Paul Arenson, CEO of Stenprop commented: "This is a significant sale for Stenprop, as Euston House is a material asset representing more than 10% by value of our portfolio. Being our last remaining central London office investment, it completes our divestment from the sector. The sale took place at a value of £95 million compared with the last reported independent valuation of £80.5 million, which was used to determine the September interim NAV of 142 pence per share.

"It also ensures that Stenprop will meet its stated milestones for the financial year ending 31 March 2019 of reducing its loan-to-value ratio to below 45% and increasing the overall MLI percentage of the portfolio to above 40%. Most significantly, the sale provides cash resources to fund additional MLI purchases in the financial year ending 31 March 2020, during which period Stenprop intends to reduce leverage further to below 40% and to acquire further MLI property so that MLI represents at least 60% of our portfolio by 31 March 2020."

 

For further information:

Stenprop Limited +44(0)20 3918 6600

Paul Arenson

Patsy Watson

Julian Carey

 

Numis Securities Limited (Financial Adviser) +44(0)20 7260 1000

Hugh Jonathan

Vicki Paine

 

Tavistock (PR Adviser) +44(0)20 7920 3150

James Whitmore

James Verstringhe

Kirsty Allan

 

Java Capital Trustees and Sponsors Proprietary Limited +27 (0)11 722 3050

(JSE Sponsor)

About Stenprop:

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISQXLFFKXFLBBL
Date   Source Headline
13th Feb 20207:00 amRNSPortfolio Update
5th Feb 202012:30 pmRNSTransaction in Own Shares
29th Jan 202012:00 pmRNSDirector/PDMR Shareholding
27th Jan 20203:00 pmRNSPosting of circular and notice of general meeting
14th Jan 20207:00 amRNSScrip dividend finalisation
30th Dec 20197:00 amRNSDirector/PDMR Shareholding
20th Dec 201910:00 amRNSDirector/PDMR Shareholding
19th Dec 20192:30 pmRNSElection to receive cash or scrip dividend
18th Dec 201912:00 pmRNSDisposal of Bleichenhof
22nd Nov 20197:01 amRNSSummarised half-year report
22nd Nov 20197:00 amRNSHalf-year Report
8th Nov 201912:00 pmRNSNotice of Results
25th Oct 20197:00 amRNSTrading update
18th Oct 20197:00 amRNSAcquisition of multi-let industrial estates
26th Sep 20197:00 amRNSAcquisition of multi-let industrial properties
20th Sep 20193:45 pmRNSResult of AGM
20th Sep 20197:00 amRNSAcquisition of multi-let industrial estates
6th Sep 201911:00 amRNSDirector/PDMR Shareholding
22nd Aug 201910:00 amRNSDirector/PDMR Shareholding
16th Aug 201910:00 amRNSDirector/PDMR Shareholding
15th Aug 20197:00 amRNSResult of election for cash or scrip dividend
9th Aug 20199:00 amRNSTransaction in Own Shares
6th Aug 20197:00 amRNSTrading update
2nd Aug 20193:30 pmRNSTransaction in Own Shares
31st Jul 20193:00 pmRNSNotice of AGM
19th Jul 20197:00 amRNSTRANSACTION IN OWN SHARES
18th Jul 20197:00 amRNSTransaction in Own Shares
16th Jul 201910:00 amRNSELECTION TO RECEIVE A CASH OR A SCRIP DIVIDEND
10th Jul 20198:00 amRNSDirector/PDMR Shareholding - amendment
9th Jul 20193:00 pmRNSScrip dividend circular
8th Jul 20192:00 pmRNSDirector/PDMR Shareholding
27th Jun 20193:00 pmRNSPosting of annual report and no change statement
10th Jun 20193:45 pmRNSDirector/PDMR Shareholding
6th Jun 20197:00 amRNSFinal Results
5th Jun 20193:30 pmRNSAppointment of interim CFO
17th May 20197:00 amRNSNotice of Results
3rd Apr 201912:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20197:00 amRNSAppointment of JSE-accredited auditor
14th Mar 20192:45 pmRNSTransaction in Own Shares
14th Mar 20197:00 amRNSCompletion of disposal of Euston House
13th Mar 201911:00 amRNSTransaction in Own Shares
12th Mar 20191:00 pmRNSDirector/PDMR Shareholding
12th Mar 20197:00 amRNSAcquisition of multi-let industrial estate
11th Mar 201910:00 amRNSTransaction in Own Shares
8th Mar 201910:00 amRNSTransaction in Own Shares
28th Feb 20197:00 amRNSTransaction in Own Shares
13th Feb 20197:00 amRNSTransaction in Own Shares
12th Feb 20191:00 pmRNSDEALING IN SECURITIES BY DIRECTOR OF THE COMPANY
12th Feb 20197:00 amRNSTransaction in Own Shares
11th Feb 20197:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.